Abstract |
Extramedullary hematopoiesis (EMH) occurs in various bone marrow disorders and is most commonly seen in thalassemia and myelofibrosis. Here, we report a patient with beta-thalassemia and nasopharyngeal carcinoma having intrathoracic EMH. Our patient is a 42-year-old man who complained of chest discomfort for a month. He was confirmed nasopharyngeal carcinoma (T3N2M0) by histopathology and received chemoradiotherapy 4 months ago. The patient had a long history of beta-thalassemia and a splenectomy due to splenomegaly at 12 years of age. Computed tomography (CT) scan of the chest showed multiple soft tissue masses in bilateral thoracic cavities. 18F-FDG-PET showed no obvious increase of fluorodeoxyglucose (18F-FDG) uptake by the lesions, with an SUVmax value of approximately 2.19. These lesions were considered EMH. The patient had been followed up for more than 1 year, and there were no changes of the lesions in the thoracic cavities.
|
Authors | Dasheng Qiu, Xiaoyan Hu, Liying Xu, Xiaofang Guo |
Journal | Journal of cancer research and therapeutics
(J Cancer Res Ther)
2015 Oct-Dec
Vol. 11
Issue 4
Pg. 1034
ISSN: 1998-4138 [Electronic] India |
PMID | 26881631
(Publication Type: Case Reports, Letter, Review)
|
Chemical References |
- Radiopharmaceuticals
- Fluorodeoxyglucose F18
|
Topics |
- Adult
- Carcinoma
- Fluorodeoxyglucose F18
- Hematopoiesis, Extramedullary
- Humans
- Male
- Multimodal Imaging
(methods)
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
(complications, pathology)
- Positron-Emission Tomography
(methods)
- Prognosis
- Radiopharmaceuticals
- Thalassemia
(complications, pathology)
- Tomography, X-Ray Computed
(methods)
|